{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:33:35Z","timestamp":1789961615421,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jid.2024.10.598","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T12:29:00Z","timestamp":1734697740000},"page":"1612-1621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Focusing on the Dark Side of the Moon: Involvement of the Nonlesional Skin in Vitiligo"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-2369","authenticated-orcid":false,"given":"Meri K.","family":"Tulic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-0549","authenticated-orcid":false,"given":"Daniela","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-354X","authenticated-orcid":false,"given":"Emanuela","family":"Bastonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-006X","authenticated-orcid":false,"given":"Stefania","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6570","authenticated-orcid":false,"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4899-6639","authenticated-orcid":false,"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.10.598_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/pcmr.12878","article-title":"The enigma and challenges of vitiligo pathophysiology and treatment","volume":"33","author":"Abdel-Malek","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2024.10.598_bib2","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/jid.2014.529","article-title":"Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo","volume":"135","author":"Agarwal","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib3","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jaad.2019.04.041","article-title":"Using the blue screen of a smartphone as an alternative to Wood\u2019s lamp for examination of vitiligo","volume":"88","author":"Agrawal","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.abd.2019.08.023","article-title":"Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis","volume":"95","author":"Akta\u015f Karabay","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/ijd.14983","article-title":"Expression of immune checkpoints in active nonsegmental vitiligo: a pilot study","volume":"59","author":"Awad","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/exd.13868","article-title":"Involvement of non-melanocytic skin cells in vitiligo","volume":"28","author":"Bastonini","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib8","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1111\/jdv.19754","article-title":"Effects of pioglitazone on the differentiation and inflammation in vitiligo keratinocytes","volume":"38","author":"Bastonini","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.10.598_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41419-021-03592-0","article-title":"A protective role for autophagy in vitiligo","volume":"12","author":"Bastonini","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2024.10.598_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059782","article-title":"Vitiligo: a possible model of degenerative diseases","volume":"8","author":"Bellei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2024.10.598_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2024.10.598_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40291-023-00672-z","article-title":"Oxidative stress and potential antioxidant therapies in vitiligo: a narrative review","volume":"27","author":"Bia\u0142czyk","year":"2023","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jid.2024.10.598_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-0749.2007.00385.x","article-title":"Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour","volume":"20","author":"Bondanza","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jid.2024.10.598_bib14","article-title":"Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo","volume":"5","author":"Boukhedouni","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2024.10.598_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","article-title":"Metabolic instruction of immunity","volume":"169","author":"Buck","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jid.2024.10.598_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/bjd\/ljad148","article-title":"Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment","volume":"189","author":"Bzioueche","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib17","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jid.2021.01.036","article-title":"Analysis of matched skin and gut microbiome of patients with vitiligo reveals deep skin dysbiosis: link with mitochondrial and immune changes","volume":"141","author":"Bzioueche","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib18","doi-asserted-by":"crossref","first-page":"9234","DOI":"10.3390\/ijms24119234","article-title":"Ceramide AD\u2122 Restores Skin Integrity and Function following Exposure to house dust mite","volume":"24","author":"Bzioueche","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2024.10.598_bib19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jaad.2019.06.022","article-title":"The association between vitiligo and diabetes mellitus: a systematic review and meta-analysis","volume":"81","author":"Chang","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jid.2024.10.598_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/cells11010038","article-title":"Molecular mechanisms and regulation of mammalian mitophagy","volume":"11","author":"Choubey","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jid.2024.10.598_bib22","doi-asserted-by":"crossref","first-page":"8820","DOI":"10.3390\/ijms22168820","article-title":"Metabolic comorbidities in vitiligo: a brief review and report of new data from a single-center experience","volume":"22","author":"D\u2019Arino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2024.10.598_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jid.2019.08.435","article-title":"Antibiotics drive microbial imbalance and vitiligo development in mice","volume":"140","author":"Dellacecca","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.0022-202x.2001.01459.x","article-title":"Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo","volume":"117","author":"Dell\u2019Anna","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13961-5","article-title":"Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin","volume":"7","author":"Dell\u2019Anna","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.10.598_bib26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1034\/j.1600-0749.2003.00087.x","article-title":"Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients","volume":"16","author":"Dell\u2019Anna","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jid.2024.10.598_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00403-015-1544-4","article-title":"A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin","volume":"307","author":"Ding","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2024.10.598_bib28","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jid.2017.02.004","article-title":"Pigmentation traits, sun exposure, and risk of incident vitiligo in women","volume":"137","author":"Dunlap","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/bjd\/ljae133","article-title":"Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK","volume":"191","author":"Eleftheriadou","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2022.11.005","article-title":"Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial","volume":"88","author":"Ezzedine","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib31","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jid.2023.04.013","article-title":"Risk of melanoma and nonmelanoma skin cancer in people with vitiligo: United Kingdom population-based cohort study","volume":"143","author":"Ferguson","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib32","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/jdv.17331","article-title":"Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: a 24-week prospective randomized placebo-controlled study","volume":"35","author":"Fontas","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.10.598_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jid.2024.10.598_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd8995","article-title":"scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function","volume":"13","author":"Gellatly","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2024.10.598_bib35","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.36849\/JDD.589a","article-title":"ARTICLE: Evolution of skin barrier science for healthy and compromised skin","volume":"20","author":"Haftek","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1069196","article-title":"Circulatory levels of alarmins in patients with non-segmental vitiligo: potential biomarkers for disease diagnosis and activity\/severity assessment","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41420-022-00863-3","article-title":"Oxeiptosis: a novel pathway of melanocytes death in response to oxidative stress in vitiligo","volume":"8","author":"Kang","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jid.2024.10.598_bib38","first-page":"629","article-title":"Association between vitiligo and relevant components of metabolic syndrome: a systematic review and meta-analysis","volume":"20","author":"Kang","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2024.10.598_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/ars.2009.2976","article-title":"Dysfunction of glutathione S-transferase leads to excess 4-hydroxy-2-nonenal and H(2)O(2) and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients","volume":"13","author":"Kostyuk","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jid.2024.10.598_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn9299","article-title":"Altered epidermal proliferation, differentiation, and lipid composition: novel key elements in the vitiligo puzzle","volume":"8","author":"Kovacs","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.jid.2024.10.598_bib41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo skin: exploring the dermal compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib42","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le Poole","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib44","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1111\/ced.13961","article-title":"Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo","volume":"44","author":"Liang","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib45","article-title":"CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2024.10.598_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14856","article-title":"The underestimated role of mitochondria in vitiligo: from oxidative stress to inflammation and cell death","volume":"33","author":"Lin","year":"2024","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib47","article-title":"Mitophagy and immune infiltration in vitiligo: evidence from bioinformatics analysis","volume":"14","author":"Luo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1055958","article-title":"Immunometabolism in the pathogenesis of vitiligo","volume":"13","author":"Lyu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0923-1811(92)90029-B","article-title":"The relationship between eosinophils, OKT6-positive cells and house dust mite (HDM) antigens in naturally occurring lesions of atopic dermatitis","volume":"3","author":"Maeda","year":"1992","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2024.10.598_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pcmr.12559","article-title":"Differential expression of CXCL9, CXCL10, and IFN-\u03b3 in vitiligo and alopecia areata patients","volume":"30","author":"Maouia","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2024.10.598_bib51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib52","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jid.2021.09.015","article-title":"Vitiligo skin T cells are prone to produce Type 1 and Type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through jak signaling","volume":"142","author":"Martins","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2023.11.017","article-title":"Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: appearances can be deceptive","volume":"153","author":"Migayron","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.aax3768","article-title":"Mitocellular communication: shaping health and disease","volume":"366","author":"Mottis","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jid.2024.10.598_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.872458","article-title":"Skin interstitial fluid and plasma multiplex cytokine analysis reveals IFN-\u03b3 signatures and granzyme B as useful biomarker for activity, severity and prognosis assessment in vitiligo","volume":"13","author":"Ng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamadermatol.2017.6401","article-title":"Atorvastatin in combination with narrowband UV-B in adult patients with active vitiligo: a randomized clinical trial","volume":"154","author":"Nguyen","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib58","doi-asserted-by":"crossref","unstructured":"Pandya AG, Ezzedine K, Rosmarin D, Passeron T, Desai TS, Lebwohl M, et al. Treatment-emergent adverse events of interest for Janus kinase inhibitors: pooled analysis of the 52-week TRuE-V Phase 3 studies of Ruxolitinib cream treatment for vitiligo. Presented at the American Academy of Dermatology (AAD) Annual Meeting, 17\u201321 March, 2023, New Orleans, LA.","DOI":"10.1016\/j.jaad.2023.07.971"},{"key":"10.1016\/j.jid.2024.10.598_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102655","article-title":"Once-daily Upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study","volume":"73","author":"Passeron","year":"2024","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.jid.2024.10.598_bib60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","article-title":"Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1468-3083.2011.04392.x","article-title":"Patients with vitiligo present fewer cardiovascular risk factors: results from a case-control study","volume":"27","author":"Rodr\u00edguez-Mart\u00edn","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.10.598_bib62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jid.2023.08.012","article-title":"The risk of keratinocyte cancer in vitiligo and the potential mechanisms involved","volume":"144","author":"Rooker","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib63","article-title":"Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies","volume":"14","author":"Sant\u2019Anna-Silva","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jid.2024.10.598_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2841814","article-title":"RNA-seq reveals dysregulation of novel melanocyte genes upon oxidative stress: implications in vitiligo pathogenesis","volume":"2019","author":"Sastry","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jid.2024.10.598_bib65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1523-1747.1998.00244.x","article-title":"Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum","volume":"111","author":"Sato","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib66","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/1523-1747.ep12492612","article-title":"Low catalase levels in the epidermis of patients with vitiligo","volume":"97","author":"Schallreuter","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib67","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/jdv.19450","article-title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force-Part 2: Specific treatment recommendations","volume":"37","author":"Seneschal","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.10.598_bib68","unstructured":"Seneschal J, Wolkerstorfer A, Ezzedine K, Pandya AG, Lynde C, Nuara A, et al. Efficacy and safety of Ruxolitinib cream through Week 104. In: Patients with vitiligo: subgroup analysis of the TRuE-V long-term extension Phase 3 study. Presented at the European Academy of Dermatology and Venereology (EADV) Congress, 11\u201314 October 2023b; Berlin, Germany."},{"key":"10.1016\/j.jid.2024.10.598_bib69","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/antiox12122082","article-title":"The impact of antioxidants on vitiligo and melasma: A scoping review and meta-analysis","volume":"12","author":"Speeckaert","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jid.2024.10.598_bib70","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jdv.14792","article-title":"Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis","volume":"32","author":"Speeckaert","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.10.598_bib71","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0378-6323.48427","article-title":"Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin","volume":"75","author":"Sravani","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2024.10.598_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.abd.2019.07.006","article-title":"Higher incidence of metabolic syndrome components in vitiligo patients: A prospective cross-sectional study","volume":"95","author":"Tanacan","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib73","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2024.10.598_bib74","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bjd.18950","article-title":"Reliability and validity of the Vitiligo Signs of Activity Score (VSAS)","volume":"183","author":"Van Geel","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib75","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1755-148X.2011.00838.x","article-title":"Koebner\u2019s phenomenon in vitiligo: European position paper","volume":"24","author":"van Geel","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2024.10.598_bib76","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaad.2016.06.015","article-title":"A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo","volume":"76","author":"Vanderweil","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib77","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/ced.13185","article-title":"Increased levels of mitochondrial DNA copy number in patients with vitiligo","volume":"42","author":"Vaseghi","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib78","doi-asserted-by":"crossref","first-page":"22173","DOI":"10.1073\/pnas.2011310117","article-title":"Human epidermal stem cell differentiation is modulated by specific lipid subspecies","volume":"117","author":"Vietri Rudan","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2024.10.598_bib79","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.12162","article-title":"Provoking factors, including chemicals, in Dutch patients with vitiligo","volume":"168","author":"Vrijman","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib80","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/jid.2015.25","article-title":"Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo","volume":"135","author":"Wagner","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib81","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/exd.14500","article-title":"IFN-\u03b3-induced PD-L1 expression on human melanocytes is impaired in vitiligo","volume":"31","author":"Willemsen","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib82","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jid.2024.02.007","article-title":"Emerging role of fibroblasts in vitiligo: a formerly underestimated rising star","volume":"144","author":"Wu","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib83","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","article-title":"Anatomically distinct fibroblast subsets determine skin autoimmune patterns","volume":"601","author":"Xu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jid.2024.10.598_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8498472","article-title":"The role of oxidative stress in the pathogenesis of vitiligo: A culprit for melanocyte death","volume":"2022","author":"Xuan","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jid.2024.10.598_bib85","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1096\/fj.07-9475com","article-title":"Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt\/beta-catenin signaling in keratinocytes","volume":"22","author":"Yamaguchi","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2024.10.598_bib86","article-title":"Metabolomics signature and potential application of serum polyunsaturated fatty acids metabolism in patients with vitiligo","volume":"13","author":"Ye","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.10.598_bib87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12895-020-00102-1","article-title":"The ceramide [NP]\/[NS] ratio in the stratum corneum is a potential marker for skin properties and epidermal differentiation","volume":"20","author":"Yokose","year":"2020","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jid.2024.10.598_bib88","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/ijd.IJD_774_19","article-title":"The difference in expression of autophagy-related proteins in lesional and perilesional skin in adult patients with active and stable generalized vitiligo-a cross-sectional pilot study","volume":"66","author":"Yu","year":"2021","journal-title":"Indian J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24028860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24028860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T09:35:18Z","timestamp":1750412118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X24028860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":86,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0022202X24028860"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.10.598","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focusing on the Dark Side of the Moon: Involvement of the Nonlesional Skin in Vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.10.598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}